CRMX is a leveraged single-stock exchange-traded fund issued under the Tradr brand by AXS Investments. Its objective is to deliver two times the daily performance of Critical Metals Corp. (CRML), a Nasdaq-listed mining exploration and development company focused on lithium and rare-earth deposits. The fund is non-diversified and holds a concentrated portfolio of derivative instruments and cash designed to maintain roughly 200% notional exposure to a single underlying security.
Because the exposure is concentrated in one pre-revenue developer, CRMX carries an expense ratio of about 1.49% and elevated single-stock, leverage, and volatility risk. Critical Metals Corp.'s flagship assets include the Tanbreez rare-earth project in southern Greenland and the Wolfsberg lithium project in Austria. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. This structure means the fund's performance is driven almost entirely by CRML's share price, with little offsetting diversification, which explains the magnitude of the recent drawdown.
Over the last 30 days, CRMX has declined approximately 70%, falling from a closing price of roughly $16.87 to a latest available price near $5.08. The move was not a steady grind but a series of sharp, high-volatility swings: the fund traded near $21 in late October before collapsing through November as selling accelerated.
The last quarter tells a similar story. Measured from a mid-August closing level near $19.72, CRMX is down roughly 74%, with the fund peaking above $32 in late September before reversing sharply. The quarterly decline was trend-driven and punctuated by extreme daily swings, reflecting both the underlying stock's volatility and the amplifying effect of daily-reset leverage.
The dominant catalyst was the completion of Critical Metals Corp.'s all-stock acquisition of European Lithium in early November. The transaction issued a substantial block of new CRML shares—about 90 million—which began trading on Nasdaq, diluting existing shareholders and prompting sustained selling pressure as newly issued shares reached the market.
Beyond the acquisition, several structural factors weighed on the fund. Critical Metals Corp. remains pre-revenue and has disclosed substantial doubt about its ability to continue as a going concern, leaving the stock highly sensitive to sentiment and financing headlines. The broader rare-earth and lithium complex also traded lower, with peers such as MP Materials (MP) and USA Rare Earth (USAR) retreating amid risk-off conditions and concerns over higher interest rates pressuring speculative, cash-burning small caps. Finally, the fund's own mechanics amplified losses: because CRMX resets its 2x exposure daily, repeated down days create volatility decay, driving multi-day returns well below a simple two-times multiple of the underlying's decline.
The three-month trend reflects a broader rotation away from speculative critical-minerals developers. Earlier in the period, CRML rallied on renewed enthusiasm for Western rare-earth supply security and Greenland-focused headlines, briefly lifting CRMX above $32. That momentum faded as investors refocused on fundamentals, including the dilutive share issuance tied to the European Lithium merger and the company's pre-revenue status.
Macroeconomic conditions compounded the unwind. Rising yields and expectations for a more restrained Federal Reserve path tend to compress valuations for unprofitable, capital-intensive developers that depend on future financing. Institutional and retail flows likewise shifted toward more liquid, lower-volatility segments, leaving leveraged single-stock vehicles such as CRMX exposed to concentrated outflows and accelerating downside.
Going forward, the factors most likely to influence CRMX are largely the same forces driving its underlying holding. Investors should monitor Critical Metals Corp.'s progress toward securing financing and advancing the Tanbreez and Wolfsberg projects, as well as any further dilution from corporate actions. A definitive feasibility study for Tanbreez is targeted for late 2027, leaving a multi-year runway of development milestones that could swing sentiment sharply in either direction.
The macroeconomic environment also matters. Interest rate expectations, inflation trends, and the appetite for risk among speculative small caps will shape the backdrop for pre-revenue critical-minerals developers. Policy developments around Western rare-earth and lithium supply chains remain a recurring catalyst for the sector. Finally, the fund's daily-reset structure means volatility itself is a headwind to long-term holders, making it a tool best suited to short-term tactical positioning rather than buy-and-hold investing.
In my own work, I often turn to Tickeron’s AI Screener when evaluating leveraged products like CRMX. It lets me apply technical indicators, volatility metrics, and industry filters to quickly surface comparable opportunities and assess signals across the market. The platform’s pattern recognition helps streamline what would otherwise be a time-consuming manual process, especially when comparing single-stock ETFs against broader sector trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CRMX saw its Momentum Indicator move below the 0 level on November 03, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator turned negative. In 15 of the 15 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CRMX turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 6 similar instances when the indicator turned negative. In 6 of the 6 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CRMX moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRMX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
CRMX broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CRMX entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +17.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRMX advanced for three days, in 25 of 27 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.